Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS (Acquired Immune Deficiency Syndrome)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03551938
What this trial is testing

We Prevent: A Dyadic Approach to HIV Prevention and Care Among Young Male Couples

Who this might be right for
HIV/AIDS
University of Michigan 318
Large-scale testing (Phase 3)Ended earlyNCT02990858
What this trial is testing

An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study

Who this might be right for
Human Immunodeficiency Virus (HIV)
CytoDyn, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT00000791
What this trial is testing

A Phase II Double-Blind Study of Two Doses of SC-49483 in Combination With Zidovudine (ZDV) Versus ZDV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 210
Not applicableStudy completedNCT01941108
What this trial is testing

Technology-Enhanced Peer Navigation to Improve IDUs' Engagement in HIV Care

Who this might be right for
HIVDrug Use
Johns Hopkins Bloomberg School of Public Health 39
Post-approval studies (Phase 4)Study completedNCT04050540
What this trial is testing

Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP

Who this might be right for
HIV InfectionsHIV/AIDSNeisseria Gonorrheae Infection+2 more
University of Washington 449
Testing effectiveness (Phase 2)Study completedNCT00000691
What this trial is testing

A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 156
Not applicableStudy completedNCT05010291
What this trial is testing

Behavioural Text Messages to Improve Retention in Care in South Africa

Who this might be right for
HIV/AIDS
University of Pennsylvania 1,541
Not applicableStudy completedNCT02402218
What this trial is testing

CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
Johns Hopkins University 144
Testing effectiveness (Phase 2)Study completedNCT00947947
What this trial is testing

Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
University of North Carolina, Chapel Hill 274
Testing effectiveness (Phase 2)Looking for participantsNCT04303117
What this trial is testing

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

Who this might be right for
Kaposi Sarcoma
National Cancer Institute (NCI) 80
Not applicableStudy completedNCT01461876
What this trial is testing

Obesity in HIV After Antiretroviral Therapy

Who this might be right for
HIVAIDSObesity
Duke University 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT02494986
What this trial is testing

A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies

Who this might be right for
Human Immunodeficiency Virus Type 1
Janssen Sciences Ireland UC 48
Testing effectiveness (Phase 2)Study completedNCT00270270
What this trial is testing

Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy

Who this might be right for
Acquired Immunodeficiency SyndromeAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 63
Not applicableLooking for participantsNCT06864273
What this trial is testing

Assessing Pharmacy Technician Educational Training for the Provision of Over-the-Counter Hearing Aids in Rural Alabama and Mississippi Pharmacies

Who this might be right for
Bilateral Hearing LossHealth Services Research
University of Alabama, Tuscaloosa 144
Not applicableStudy completedNCT00001560
What this trial is testing

Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

Who this might be right for
Acquired Immunodeficiency SyndromeKaposi's SarcomaLeukemia+3 more
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT01459120
What this trial is testing

Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural Lesotho

Who this might be right for
HIV/AIDSTuberculosisDiabetes Mellitus+1 more
SolidarMed 1,800
Not applicableEnrolling By InvitationNCT06350682
What this trial is testing

Resilient HIV Implementation Science With SGM Youths Using Evidence

Who this might be right for
Hiv
University of Maryland, Baltimore 1,500
Not applicableStudy completedNCT00000896
What this trial is testing

Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT00002108
What this trial is testing

3TC (Lamivudine; GR109714X) Open-Label Program

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)UnknownNCT01793818
What this trial is testing

Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein

Who this might be right for
AIDS
BIOSANTECH 50
Next Page